Business
Jefferies reiterates Buy rating on Praxis Precision Medicines stock, cites FDA breakthrough designation

Jefferies reiterates Buy rating on Praxis Precision Medicines stock, cites FDA breakthrough designation
Published
4 weeks agoon
By
NewsAdmin
Jefferies reiterates Buy rating on Praxis Precision Medicines stock, cites FDA breakthrough designation